Research and Markets: Biopharmaceuticals Market Trends & Competition - Now Available

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/e774aa/biopharmaceuticals) has announced the addition of the "Biopharmaceuticals Market Trends & Competition" report to their offering.

Today's pharmaceutical industry is shifting toward biopharmaceuticals at a drastic speed. In 2009, sales of biopharmaceutical drugs accounted for 13% of the total sales of pharmaceuticals. And today, biopharmaceuticals account for 25% of all pharmaceuticals in the development pipeline. We expect that biopharmaceuticals will maintain double digit growth in the years to come, and form a rapidly growing market.

Eyeing this dramatically expanding market, companies are expanding biopharmaceutical discovery and development, and becoming active in M&A activities including involvement in bio-ventures. As a result, competition is becoming increasingly fierce.

Disease Categories: Alzheimers disease, Anemia, Arthritis, Asthma, Cancer, CAPS, Diabetes, Fabry disease, Gaucher's disease, Growth hormone deficiency, Hepatitis C, HIV, Lupus, Multiple sclerosis, Neutropenia, Osteoporosis, Parkinson's disease, Transplant rejection, Ulcerative colitis, Vaccines, Other conditions.

Key Topics Covered:

1. Market Overview

2. Worldwide Biopharmaceutical Drug Market Trends, 2009-2013

3. US Biopharmaceutical Drug Market Trends

4. Worldwide Innovative Biopharmaceutical Dug Development by Disease Category

5. Worldwide Biopharmaceutical Drug Strategies by Major Company

6. Important Findings and Suggestions for Business Opportunities

Companies Mentioned:

  • Abbott Laboratories
  • AMBiS
  • Amgen
  • Bayer
  • Biogen Idec
  • Bristol-Myers Squibb
  • Chugai Pharmaceutical Co. Ltd.
  • Daiichi Sankyo Co. Ltd.
  • Elan
  • Eli Lilly
  • Genetech
  • Genzyme
  • GlaxoSmithKline
  • Hayashi Kasei Co. Ltd.
  • Human Genome Sciences
  • Johnson & Johnson
  • Katakura Industries Co. Ltd.
  • Kyowa Hakko Kirin Co. Ltd.
  • Merck
  • Merck Serono
  • Neosilk Co. Ltd.
  • Novartis
  • Novo Nordisk
  • + many more

For more information visit http://www.researchandmarkets.com/research/e774aa/biopharmaceuticals



CONTACT:

Research and Markets
Laura Wood, Senior Manager,
[email protected]
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

KEYWORDS:

INDUSTRY KEYWORDS:   Health  Pharmaceutical  Other Health

MEDIA:

Logo
 Logo

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.